Margetuximab-Cmkb: Benefits, Reviews, Info, Side Effects!
Margetuximab-Cmkb is a monoclonal antibody that has been approved by the FDA for the treatment of HER2-positive breast cancer. This drug works by targeting the HER2 receptor, which is overexpressed in